Oral Answers to Questions

Debate between Chris Green and Maggie Throup

Tuesday 23rd November 2021 Commons Chamber

[Maggie Throup]

As I said earlier, we have already vaccinated over 1.1 million 12 to 15-year-olds since the roll-out began, which to me is a huge success. We have opened up the national booking service, and provided more opportunities for youngsters to come forward whether within the school environment or outside the school environment. We always look at every opportunity to ensure complete accessibility for people to get their vaccine.

[Chris Green (Bolton West) (Con)]

9. What steps his Department is taking to increase the number of carers in the adult social care sector.

Coronavirus Act 2020 (Review of Temporary Provisions) (No. 3)

Debate between Chris Green and Maggie Throup

Tuesday 19th October 2021 Commons Chamber

[Maggie Throup]

Covid certification will be brought in under the Public Health (Control of Disease) Act 1984, which, as my right hon. Friend is aware, allows for emergency measures. We will do our utmost to bring forward the vote in Parliament before any enactment of the need for covid certification.

I return to the comments by my hon. Friend the Member for Bolton West. A consultation about making vaccination a condition of deployment in the NHS and wider social care closes on 22 October. We will consider all the responses in due course.

[Chris Green]

Does my hon. Friend share my constituents’ perplexity and confusion that the Government think it is suitable to have compulsory vaccination in care home settings—that has been their intention for many weeks—yet they are still confused or undecided as to whether that is equally relevant in the NHS? Carers are going from care settings into the NHS at the moment.

[Maggie Throup]

I reiterate that we are consulting at the moment for the NHS and other social care settings, and we are not moving the dates that we have already set for vaccination as a condition of deployment in care homes.

The hon. Members for Brent Central (Dawn Butler) and for Twickenham (Munira Wilson), my right hon. Friend the Member for Haltemprice and Howden (Mr Davis) and my hon. Friend the Member for Wycombe (Mr Baker) raised the issue of unlawful convictions. I reassure them that since April 2020, the Crown Prosecution Service has reviewed all prosecutions under the Coronavirus Act, and it continues to do so. As such, the issue is primarily administrative, rather than one of the wrongful use of powers provided by the Act. That policy of review by the CPS has provided an effective safeguard. All incorrect charges made under the Act and reviewed by the CPS have been overturned, and updated guidance has been issued to the police.

Covid-19: Vaccination of Children

Debate between Chris Green and Maggie Throup

Tuesday 21st September 2021 Westminster Hall

[The Parliamentary Under-Secretary of State for Health and Social Care (Maggie Throup)]

I thank my hon. Friend the Member for Penistone and Stocksbridge (Miriam Cates) for securing this important and timely debate on the vaccination of 12 to 15-year-olds against covid-19. She quite rightly highlighted the importance of vaccine roll-outs and the programmes that we have had for many decades, and I thank her for that.

Before I respond to the various questions and points raised by hon. Members, I pay tribute to my predecessor, my right hon. Friend the Member for Stratford-on-Avon (Nadhim Zahawi), for his efforts in successfully delivering the vaccine programme, with more than 93 million doses administered in the UK and more than four fifths of adults receiving the protection of two jabs. I aim to build on that very solid foundation in my new role.

I also put on record that I am very grateful to everyone who has played a crucial role in the success of the vaccine roll-out, from our brilliant scientists, clinical trial participants, the armed forces, NHS England, frontline healthcare workers, vaccine volunteers and local and central Government. Our jabs have already prevented more than 112,000 deaths, 230,000 hospitalisations and more than 24 million infections. They have built a vast wall of defence for the British people.

Earlier this year, our medicines regulator, the MHRA, approved the Pfizer and Moderna vaccines for 12 to 17-year-olds. The MHRA authorisation decision confirmed that vaccines are safe and effective for this age group. On this decision, the Joint Committee on Vaccination and Immunisation recommended vaccination for 12 to 15-year-olds with serious underlying health conditions. In August, the committee advised an initial dose of the vaccine for all healthy remaining 16 and 17-year-olds. The JCVI then looked at whether we should extend our offer of vaccination to all 12 to 15-year-olds. It concluded that there are health benefits to vaccinating this cohort, although they are finely balanced.

However, the JCVI’s remit does not include the wider impacts of vaccinations, such as the benefits for children in education or the mental health benefits that come from people knowing that they are protected from this deadly virus. The JCVI therefore advised that the Government might wish to seek further views on those wider impacts from the UK’s chief medical officers across all four nations. The Secretary of State and the Health Ministers from the devolved nations accepted that advice. Our CMOs consulted clinical experts and public health professionals from across the United Kingdom, such as those from the Royal College of Paediatrics and Child Health. I trust that that reassures my hon. Friend the Member for Northampton South (Andrew Lewer), who raised concerns about professional advice.

We received advice from the four chief medical officers, and it was made publicly available and deposited in the Library for Members to read in full. The unanimous recommendation of the UK’s chief medical officers is to offer all remaining 12 to 15-year-olds a first dose of the Pfizer vaccine, with further JCVI guidance needed before any decision on a second dose. The CMOs have been clear that they make this recommendation based on the benefits to children alone, not on the benefits to adults or wider society.

I can confirm that the Government accepted this recommendation. We are now moving forward with the same sense of urgency that we have had at every point in our vaccination programme. I am delighted that a 14-year-old in Essex yesterday became one of the first children in the country to receive a covid-19 vaccination in school.

[Chris Green]

Will my hon. Friend set out exactly why it is recommended for adults to have two doses and perhaps later a booster dose of the vaccine, but for children it is a single dose?

[Maggie Throup]

I thank my hon. Friend for his intervention, and I reassure him that the evidence is continually being observed and recorded. Further advice will be taken on whether a second dose is needed for the younger age range. Evidence is being gathered all the time.

I appreciate that there are questions about how the process of consent will work in circumstances where parents and children disagree. I reassure my hon. Friend the Member for St Ives (Derek Thomas) that, as with all vaccinations for children, parental consent will be sought. The consent process is being handled by each school in its usual way and provides sufficiently for parents to give their consent. Children aged 12 to 15 will also be provided with information, usually in the form of a leaflet for their own use and to share and discuss with parents prior to the date on which the immunisation is scheduled.

Parental, guardian or carer consent will be sought by the school age immunisation service prior to vaccination, in line with other school vaccination programmes. That service will carry out the vaccinations, and I trust that that reassures my hon. Friend the Member for Northampton South. The school age vaccination service has vast experience of dealing with a number of other vaccine roll-outs in secondary schools, such as the human papillomavirus vaccine and the three-in-one teenage booster that protects against tetanus, diphtheria and polio. The clinicians who work on these roll-outs are very well equipped and very well versed in dealing with vaccines in schools.

In their advice, the four CMOs have said it is essential that children and young people aged 12 to 15, and their parents, are supported in whatever decisions they take, and that they are not stigmatised for accepting or not accepting the vaccination offer. Individual choice should be respected. It is the opportunity to be vaccinated that is on offer, in a fair and equitable manner.

To those who remain undecided, I say this. The MHRA is the best medical regulator in the world. It has rigorously reviewed the safety of our vaccines, and it only authorises those that it concludes are safe. Vaccines for children and young people are no exception. We continue to have a comprehensive safety surveillance strategy in place across all age groups to monitor the safety of all covid-19 vaccines that are approved for use in the UK.

I will now address some of the interventions and questions from hon. Members. My hon. Friend the Member for Penistone and Stocksbridge asked a number of questions. I reiterate that the CMOs sought advice from experts in the field; it was not just the information they had themselves. It is only right that, based on that advice, 12 to 15-year-olds are able to take up the offer of the vaccine in a fair and equitable manner.

My hon. Friend asked about disruption to education from the programme. NHS England already has plans in place for the mop-up programme, which is not likely to be on school sites, to minimise disruption to education and the rest of the immunisation programme.

[Maggie Throup]

I thank my hon. Friend for that intervention. It is important that we do whatever we can—use whatever we have in our toolbox—to make sure that children are able to continue with their education, and vaccination is one part of that. I know my hon. Friend is passionate, as am I, about making sure that children get a full education, and that the pandemic does not affect their futures. My hon. Friend raised several other questions and, if she will allow me, I will write to her in response to any I do not answer in my speech.

My hon. Friend the Member for Lincoln (Karl MᶜCartney) raised questions about guidance for schools on the vaccination programme. How the programme will work has been set out very clearly, including in the formation of the consent process, most recently updated on 17 September 2021. I would like to reassure my hon. Friend, who highlighted the three words “do no harm”, that robust monitoring arrangements are in place for the vaccination of 12 to 15-year-olds, and that further data will be available shortly.

I join the hon. Member for Leicester West (Liz Kendall) in absolutely condemning the threats and intimidation of headteachers, school staff and anybody who enters school premises. That is a big issue, and my advice is that headteachers who have received such intimidation should rapidly contact the school age immunisation service, which is well versed in addressing it. They should not be afraid to speak to the police and the local authority too. I assure her that that issue is extremely high on my priority list, which, as she can imagine, is getting longer.

It is important that we remember that our teenagers have shown great public spirit at every point during the pandemic, and I thank them for that. They have stuck to the rules so that lives can be saved and people kept safe, and they have been some of the most enthusiastic proponents of vaccines.

[Chris Green]

Certain drug companies are now looking to get approval for vaccinations for five-year-olds. Does the Minister rule that in or out in the United Kingdom?

[Maggie Throup]

My focus at the moment is on ensuring the effective roll-out of the programme for 12 to 15-year-olds. We must ensure that the booster programme is rolled out effectively, and encourage the last few people who have not yet had the vaccine—I think it is about 5 million—to take up that offer.